Acid suppression after esophageal atresia repair: Some infants do benefit

Suhail Zeineddin1,2, Gwyneth A Sullivan1,2,3, J Benjamin Pitt1,2

  • 1Division of Pediatric Surgery, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.

Insights

Acid suppression therapy may reduce stricture rates in infants undergoing complex esophageal atresia/tracheoesophageal fistula (EA/TEF) repair. For simple EA/TEF cases, acid suppression showed no significant benefit in preventing anastomotic strictures.

Area of Science:

  • Pediatric Surgery
  • Gastroenterology
  • Neonatal Care

Background:

  • Acid suppression is commonly used post-esophageal atresia/tracheoesophageal fistula (EA/TEF) repair to prevent anastomotic strictures.
  • Recent evidence has questioned the efficacy of acid suppression in this context.
  • This study investigates the association between acid suppression and stricture rates in a large infant cohort.

Purpose of the Study:

  • To compare anastomotic stricture rates in infants undergoing EA/TEF repair with and without acid suppression.
  • To determine if acid suppression is beneficial for preventing strictures in simple versus complex EA/TEF cases.

Main Methods:

  • A nationwide sample of infants undergoing EA/TEF repair (2010-2022) was analyzed using the Pediatric Health Information System.
  • Acid suppression was defined by H2 blocker or PPI use.
  • Complex EA/TEF repair included criteria like delayed repair, G-tube placement, prolonged hospitalization, or multiple fluoroscopies. Stricture dilation was the primary outcome.

Main Results:

  • Among 1445 infants, 17.8% required dilation by 1 year.
  • For simple EA/TEF, stricture rates were similar with or without acid suppression (17.5% vs. 17.0%, p=0.90).
  • In complex EA/TEF cases, those receiving acid suppression had significantly lower stricture rates (15.3% vs. 26.0%, p=0.001).

Conclusions:

  • Postoperative acid suppression is associated with reduced stricture incidence in complex EA/TEF repair.
  • Reducing acid suppression may be appropriate for simple EA/TEF repairs.
  • Acid suppression should be considered for infants with complex EA/TEF to mitigate stricture risk.
Abstract

Related Concept Videos

Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
212
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
301
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
158
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids01:31

Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids

In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
446
Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
269
Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
207